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ABSTRACT 
Background: Crystalline penicillin is one of the commonly prescribed antibiotics used for the treatment of certain susceptible 
bacterial infections over several years in Ethiopia. However, little is known about the appropriateness of clinical indication, dose and 
frequency of administration, duration and therapeutic outcome of patients in general and pediatrics in particular. Therefore, the study 
aimed to evaluate the rational use of crystalline penicillin injection in pediatrics ward of Hiwot Fana Specialized University Hospital 
(HFSUH), Eastern Ethiopia. 
Methods: Retrospective cross sectional study was employed for evaluating medication records of hospitalized pediatric patients who 
received crystalline penicillin from Dec 1, 2015- Feb 29, 2016 at pediatrics ward of HFSUH. Based on Joint Commission on 
Accreditation of Healthcare Organizations (JCAHCO) criteria, 114 medical records (20%) were selected by systematic random 
sampling from the total of 570 records. The study was conducted from Mar 1-Mar 15, 2016. Besides, the data were evaluated against 
Standard treatment guideline (STG) of Ethiopia for general hospitals and World Health Organization (WHO) drug use evaluation 
guideline  
Results: Among the 114 medical records of pediatric patients included in the study, the dose and frequency of administration, 
contra-indications and drug interactions of crystalline penicillin were according to the STG of Ethiopia for general hospitals, and 
WHO Guidelines for the management of common illnesses in children in areas with limited resources. All the 114 (100%) cases 
were consistent with guidelines for contra-indications and drug interaction of crystalline penicillin use. Moreover, 108(94.74%) and 
112 (98.24%) of the cases were in accordance with the guidelines for the dose and frequency of administration, respectively. 
However, 93 (81.58%), 59 (51.75%) and 59 (51.75%) of the patient cases were not according to the guidelines of crystalline 
penicillin use for indications, duration and outcome of therapy, respectively. 
Conclusion: Crystalline penicillin utilization pattern in pediatric ward of HFSUH has fully adhered to the STG of Ethiopia for 
general hospitals and WHO Guideline for the majority of the parameters with regard to dose and frequency of administration, 
contraindications, and drug interactions as well as met the thresholds set for most of the DUE criteria. However, indication, duration 
and outcome of therapy were not in accordance with the guideline.  
Keywords: Drug use evaluation; Pediatrics; medication records; crystalline penicillin; Standard treatment Guidelines; World Health 
Organization   
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INTRODUCTION  
DUE is a system of ongoing, systematic criteria based 
evaluation of drug use to ensure whether medicines are 
used properly at the individual patient level 
1
. DUE may 
be applied to an individual drug, therapeutic categories, 
clinical condition (disease state), utilization process or 
therapeutic outcomes of drugs 
2
. DUE can address the 
actual process of medication administration, prescribing, 
and dispensing activities. It involves a comprehensive 
review of patients’ prescription and medication data 
before, during and after dispensing for ease of 
appropriate decision making and positive therapeutic 
outcome 
3
. If properly designed, DUE provides not only 
a means of identifying drug use problems but also a 
means to correct the problem and there by contribute to 
rational drug therapy 
4
. 
The potential inappropriate utilization of drugs has 
become a major global concern given increment in 
variety and quantity of pharmaceutical products. 
Potentially inappropriate use of medication is associated 
negative health impact to the patient and wastage of 
financial resources to the health facilities and the 
patients as well. Hence, numerous studies have tried to 
address this issue and designed strategies to probe and 
resolve the problem as well as to prevent it 
5
.  
Concerning the use of medicines in infants and children, 
there are certain unique set of challenges to the 
prescribers. It is obvious that safety, efficacy, pharmaco-
kinetic and pharmacodynamic profile of medicines are 
influenced significantly by physiological variances 
between children and adults. However, most pharmaco-
kinetic and pharmacodynamic studies provide little 
information on drug action in neonates, infants and 
children, due to exclusion of this age group in many 
experimental studies
6. The ‘Better Medicine for 
Children’ slogan of 2007, World Health Assembly, 
recognized the need for research and development on 
childhood medicines including better dosage forms, 
better evidence and better information about how to 
ensure that medicines for treating the common childhood 
diseases are given at the right  dose for children of all 
ages 
7
.  
The increased prevalence of known resistant organisms 
and the emergence of newly resistant organisms have 
resulted in prolonging the treatment and length 
hospitalization, which in turn results in increased direct 
and indirect healthcare costs to the patients. Therefore, 
evaluation of antimicrobial use is essential for checking 
whether the appropriate usages of antimicrobial agents 
are present 
8
. An improvement of resistances can be 
achieved by temporary reduction of the use of the 
respective categories of antibiotics 
9
. 
DUE is one of the methods used in combating the 
development of bacterial resistant to anti-microbial 
agents and improving therapy. DUE is a performance 
improvement method that focuses on evaluating and 
improving drug use processes to achieve optimal patient 
outcomes 
10, 11
. DUE is of three types; prospective, 
concurrent and retrospective. A retrospective DUE is the 
simplest to perform since drugs therapy is reviewed after 
patient has received the medication. A retrospective 
review may detect patterns in prescribing, dispensing or 
administering drugs to prevent recurrence of inappro-
priate use and serves as a means for developing 
prospective standards and target interventions 
1, 12
. Thus, 
the aim of the study was to evaluate the utilization of 
crystalline penicillin injection in pediatrics ward of 
HFSUH. 
METHODS  
Study area and period 
Harar is located 526 Km away from Addis Ababa to the 
east. Harari Region is  one  of  the  nine National Regio-
nal  States  of Ethiopia, with  the  town of Harar  as  its  
capital. Based on the 2007 Census result of the CSA, 
Harari has a total population of 183,344, of which 
92,258 were male and 91,086 female; 99,321 or 54.17% 
of the population were urban inhabitants. In the region, 
there are 4 governmental hospitals, 1 NGO and 2 private 
hospitals, and 8 health centers 
13
. Among the govern-
mental hospitals, this study was conducted in pediatric 
wards of HFSUH from March 1-15, 2016 G.C.  
Study design   
Hospital based retrospective cross-sectional study design 
was employed to evaluate utilization pattern of 
crystalline penicillin in pediatric ward of HFSUH in the 
study period.   
 Population 
All pediatric patient medication records containing 
crystalline penicillin in HFSUH was used as a source 
population for this study. Medication records with 
crystalline penicillin use for the specified three months 
(quarter of a year) (Dec 1, 2015-Feb 29, 2016) was 
considered as study population from which sampling 
units were drawn. 
Sample size determination and sampling technique  
According to the Joint Commission on Accreditation of 
Healthcare Organizations (JCAHCO) criteria which 
mandates: - if the average number of cases per quarter is 
more than 600, at least 5% cases are reviewed; if the 
number of cases per quarter is fewer than 600, at least 30 
cases are reviewed and if there are fewer than 30 cases 
per quarter, then 100% of the cases are reviewed 
14
. 
Based on these criteria, patient medication records 
containing crystalline penicillin and targeting pediatric 
patients was considered retrospectively for a quarter 
(Dec 1, 2015-Feb 29, 2016). From the study which 
encompassed data of three month crystalline penicillin 
use in pediatric ward, the number of cases (crystalline 
penicillin indication) per quarter was found to be 570. 
Therefore, to obtain greater point estimate of population, 
about 114 (20%) medication records were taken as the 
final sample size which is much greater than the 
minimum sample size (n=30) as per JCAHCO recom-
mendation.  
Once the sample size had been determined for the study, 
systematic random sampling was employed to obtain 
sample population. Sampling frame was prepared by 
coding 570 medication records according to the 
chronological order (date of records) and sampling 
interval was calculated as follows  
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K=study population/calculated sample size =570/114 = 5 
Once the first sample was randomly selected, all the rest 
samples were taken by picking every 5
th
 of the medical 
record until the aforementioned sample size was 
obtained 
Variables  
Dependent variables  
Drug use evaluation of crystalline penicillin  
Independent variable  
Variables including socio-demographic characteristics of 
pediatric patients (age, sex), clinical characteristics (co-
morbidity, nature and severity of infection, underlying 
medical conditions, nature of diagnosis and treatment 
modalities, prevalence of infections) etc are among the 
factors that ultimately affect utilization pattern of 
crystalline penicillin in the pediatric ward.  
Data collection instrument and techniques  
After all preliminary preparations were completed for 
data collection; data were collected retrospectively using 
structured observational check list (data abstraction 
format) from medication records of pediatric patients 
during the study period.  
Data quality control 
Pre testing was done to check whether the data 
collection format was valid and reliable. The data were 
checked and cleared every day for ensuring complete-
ness and consistency before undergoing data processing 
and analysis. 
Data processing and analysis 
The collected data were entered and processed using 
SPSS v21 (SPSS Inc., Chicago, IL, USA). Besides, the 
data were evaluated against Standard treatment guideline 
(STG) of Ethiopia for general hospitals and WHO DUE 
guideline. As there is no STG for teaching and referral 
hospitals, drug use evaluation criteria with thresholds 
was set based on the national STG of Ethiopia for 
general hospitals, WHO guide for DUE and WHO 
Guidelines for the management of common illnesses in 
children in areas where limited resources are highly 
noticeable 
4,15,16
. The DUE criteria for crystalline 
penicillin utilization was presented below (Table 1) 
 
Table 1:  Drug use evaluation criteria for crystalline penicillin. 
Indicator  Criteria  Threshold 
Indication Severe Pneumonia 
Pyogenic meningitis (Meningococcal meningitis and Pneumococcal meningitis)  
Generalized Neonatal tetanus 
Congenital syphilis 
Neonatal sepsis 
Cellulites 
Erysipelas 
Endocarditis 
100 
Dose and dose 
frequency 
Bacteremia:  25,000 to 50,000 units/kg/dose IV infusion over 30 minutes, or IM 
Severe Pneumonia: 50,000 units/kg/24 hours IV QID 
Meningococcal meningitis:  250,000 units/kg/dose IV infusion over 30 minutes, or IM 
every 4 hour 
Pneumococcal meningitis:  250,000 units/kg/dose IV infusion over 30 minutes, or IM 
every 4 hour 
Neonatal sepsis:  50,000 IU/kg/24hours IV QID 
Neonatal tetanus: 50,000 IU/kg/24hours IV QID 
Cellulites:  50,000 IU/kg/24hours IV 4 hourly 
Erysipelas: 50,000 IU/kg/24hours IV 
Prevention of Bacterial Endocarditis:  50,000 IU/kg intravenously or intramuscularly 
30 to 60 minutes before the  
procedure and, 1 million IU (25,000 IU/kg for children) six hours later 
Gonococcus infection (only with proven penicillin-susceptible isolate): 100,000 
units/kg/dose IV infusion over 30  
minutes, or IM 
Congenital syphilis: 50,000 units/kg/dose IV over 30 minutes, given Q 12 hours during 
the first 7 days of life 
95 
Duration Congenital syphilis:  10-14 days 
Severe Pneumonia: 3 days 
Meningococcal meningitis:  10 days 
Pneumococcal meningitis:  7 days 
Neonatal sepsis: 10 days 
Neonatal tetanus: 10 days 
Cellulites:  10 days 
Erysipelas: until the fever subside 
Endocarditis: 2-6 weeks 
90 
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Contra-
indications 
Penicillin hypersensitivity reaction; avoid intrathecal route 100 
Drug 
interactions 
Methotrexate, 
• Probenecid (decrease renal tubular secretion of the penicillin’s),  
•Aminoglycosides (inactivated by high doses of IV benzyl penicillin; should not be 
administered in same IV set. 
90 
Outcome  Fever reduction  
Decrease of at least 1°C from peak temperature within 3 days of initial crystalline 
penicillin dose 
Fever not present initially 
Clinical improvement noted in progress 
New organism or another infection suspected or identified 
Patient discharged before therapy completed and unavailable for follow-up 
Patient expired & Switch to oral therapy 
95 
 
RESULTS  
Socio demographic characteristics 
In this drug use evaluation study, as per JCAHCO 
recommendation, a total of 114 medical records 
containing crystalline penicillin injection and targeting 
pediatric patients at HFSUH was evaluated for their 
therapeutic appropriateness. From these cards, the 
majority of patients were found to be male 61 (53.51%) 
and the majority of age group falls under 1-5 years 57 
(50.00%) (Table-2). 
 
 
Table 2: Age-sex distribution of pediatric patients at the HFSUH  pediatric ward from Dec 1, 2015- Feb 29, 2016.  
 
Modalities of crystalline penicillin use, appropriate-
ness of indication and dosage  
Out of the pediatric medical records reviewed, the 
predominant use of crystalline penicillin was for 
empirical treatment which accounts 70(61.41%), 
followed by definitive treatment with the evidence of 
laboratory diagnosis in case of 44(38.59%) patients; 
however, no data were registered for prophylactic use. 
Besides, out of the total records, 93 (81.58%) medication 
records contain correct indication of crystalline 
penicillin according to the guideline whereas, 108 
(94.74%) patient medication records contain correct 
dose of crystalline penicillin (Table 3). 
  
Table 3: therapeutic modalities, appropriateness of indication and doses of crystalline penicillin at pediatric wards of 
HFSUH from Dec1, 2015-Feb 29, 2016 (n= 114) 
 
Disease state for which crystalline penicillin was 
indicated 
Based on the data on table 3, 93 (81.58%) medical 
records contain crystalline penicillin with appropriate 
indications including severe pneumonia 70 (75.27%), 
community acquired pneumonia 11(11.83%), congenital 
syphilis and HADD, each 6 (6.45%) and these are the 
common diseases to which crystalline penicillin was 
prescribed in the study setting. Apart from this, 
Socio-demographic characteristics  Frequency  % 
Gender Female  53 46.49 
Male  61 53.51  
Age < 1 month (neonate)   - - 
1-12 month (infant)   46 40.35 
1-5 years  57 50.00 
6-10  5 4.39 
>10 years  6 5.56 
Study parameters  frequency %  
Ways of therapy  Empirical therapy  70 61.41  
Definitive therapy  44 38.59 
Prophylactic therapy  --- -- 
Indication  Correctly indicated  93 81.58 
Not correctly  indicated  21 18.42 
Dose  Correct dose  108 94.74 
Incorrect dose  6 5.26 
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indications of crystalline penicillin for some disease 
were not concordant with STG of Ethiopia and DUE 
guideline of the WHO. The incorrect indications include 
recurrent severe pneumonia 7 (30%), acute gastro-
enteritis and pertusis each account 4 (19.04%) (Table-4).  
 
Table 4: Disease state for which crystalline penicillin was indicated at pediatric ward of HFSUH from Dec 1, 2015- Feb 
29, 2016 (n=114) 
Indications   Frequency  %  
Correct indications  
(n=93)  
Severe pneumonia  70 75.27  
Community acquired pneumonia  11 11.83 
Congenital syphilis  6  6.45 
HAAD  6  6.45 
Incorrect indications  
(n=21)  
Recurrent severe pneumonia  7 30.00 
Acute gastro enteritis  4 19.04 
Pertusis  4 19.04 
Ascites with hypertension II  2 ----- 
Chicken pox 2 ----- 
Typhus  2 ----- 
 
Frequency at crystalline penicillin given 
Given the indication, about 98.14% records were found 
to be correct frequency of administration (i.e. 4 times 
(12.96%) and 6 times (85.16%)) while 1.85% is not 
correct. The most common frequency of administration 
of crystalline penicillin injection was found to six 
times daily (Figure 1).    
Duration at crystalline penicillin given 
Coming to the duration of treatment with crystalline 
penicillin injection,  the most common duration of 
therapy was found to be five days and above (23.68%) 
followed by two and three days (18.42% each) (Table 
5). 
Table 5: Duration of therapy for the crystalline 
penicillin injection at pediatric wards of HFSUH from 
Dec 1, 2015- Feb 29, 2016 (n=114) 
Duration of therapy (day) Frequency  % 
Unspecified  15 13.16 
One  19 16.67 
Two  21 18.42 
Three  21 18.42 
Four  11 9.65 
Five and above  27 23.68 
Total  114 100 
 
Status of laboratory diagnosis 
In this study, the top laboratory diagnosis done for 
pediatric patients were complete blood count (CBC) 
with WBC differential 51 (44.74%), blood film 
25(21.93%), X-ray 15(13.16%) and Hgb 11(9.65%) 
(Table-6). 
 
Figure 1: Frequency of crystalline penicillin injection 
per day at pediatric wards of HFSUH 
Table 6: Presence of laboratory-diagnosis justifying involvement of susceptible strain at pediatric wards of HFSUH 
from Dec 1, 2015- Feb 29, 2016 (n=114) 
Type of laboratory  tests  Frequency                     Results       % 
+ve -ve 
White blood cell  51  21  30 44.74%  
Blood film  25  - 25 21.93%  
X-ray  15 4 11 13.16%  
Hgb  11 7  4  9.65%  
ESR  6 4  2 5.26%  
Stool analysis  2 2 -- 1.75%  
WIDAL(ww)  2  2 -- 1.75%  
Wieflex(wwf)  2 2  --  1.75%  
ESR=erythrocyte sedimentation rate; Hgb=Haemoglobin 
0 
10 
20 
30 
40 
50 
60 
70 
80 
90 
100 
2 times 4 times 6 times 
1.85% 
12.96% 
85.18% 
p
e
rc
e
n
t 
dose frequency  
Abdela et al                                                                                         Journal of Drug Delivery & Therapeutics. 2017; 7(2):62-69                                       
ISSN: 2250-1177                                                                    [67]                                                                  CODEN (USA) JDDTAO 
Co-administered drugs with crystalline penicillin 
About 87.04% crystalline penicillin charts contain co-administered drugs without any noticeable drug interactions 
observed. However, the rest (12.96%) medical records contain crystalline penicillin only (Figure 2). 
 
Figure 2: Co-administered drugs with crystalline penicillin at pediatric ward from Dec 1, 2015- Feb 29, 2016 (n=114) 
 
Patient outcomes measurements  
According to this study, from the total of 114 pediatric 
patient charts reviewed, about 59 (51.75%) patients 
improved, 36 (31.58%) patient outcomes not specified, 
11(9.65%) patients self-discharged, and 8 (7.4%) 
patients expired (Table 7).   
Table 7: The observed outcomes of pediatric patients at 
HFSUH from Dec 1, 2015- Feb 29, 2016 (n=114) 
Final out comes  Frequency      % 
Improved   59  51.75%  
Unspecified  36  31.58%  
Self- discharged  11 9.65%  
Expired (dead)  8 7.02%  
Total  114 100%  
 
Table 8: Evaluation of overall DUE indicators against 
the threshold value  
Criteria  Observed 
(%) 
Threshold 
(%) 
Indication   81.58 100 
Dose & dose frequency 
(average) 
96.29 95 
Duration   51.75 90 
Contra-indications (absence) 100 100 
Drug interactions (absence) 100 90 
Outcome  51.75 95 
 
Coming to the overall assessment of crystalline 
penicillin utilization, promising results were obtained in 
cases of dose and frequency of administration, contra-
indication, and drug-drug interactions. However, when 
the observed data were compared to the threshold value, 
clinically sound deviation was observed in cases of 
indication, duration and outcome of crystalline penicillin 
therapy (Table 8).  
DISCUSSION 
The ultimate objective of DUE is to ensure that drugs 
are used in safe, economically viable, cost-effective 
approach in order to improve the therapeutic outcome of 
patients. Besides,  with the aid of DUE, progressive 
improvement in the utilization pattern of drugs have 
several positive impacts on the healthcare delivery 
including lowering the healthcare cost to the individual 
patient and to the facility, reducing adverse drug 
reactions and drug interaction, improving patient 
adherence and maximizing therapeutic outcomes 
4,5
.  
Antibiotic stewardship programs should be designed to 
optimize treatment and make sure that patients receive 
antibiotics promptly and only when needed. They make 
sure that patients receive the right antibiotic at the right 
dose and for the right length of time, improving 
prescribing in hospitals and long-term care facilities, 
saving money, and saving lives 
17
. The implementation 
of antibiotic guidelines or protocols has been shown to 
be a formal means of achieving the goals of appropriate 
antibiotic utilization, limiting unnecessary antibiotic use 
and, as a result, improving antibiotic susceptibility 
profiles 
18
.  
Successes of therapy largely relies on the knowledge of 
the physicians to diagnose the disease, select the right 
drugs, dose, dosage form and routes of administration, 
and without probable or suspected adverse reactions, 
drug interactions, and unnecessary duplication of 
therapy. Developing and applying hospital based drug 
formulary and STGs can be considered as a basis for 
promoting rational drug use. Drugs have to be prescribed 
(indicated) appropriately on the basis of clinical diseases 
identified through diagnosis. Hence, prescribers should 
stick with STGs while prescribing any drug 
4, 16
.  
In this finding, 114 medication records which contain 
crystalline penicillin were taken from pediatric wards.  
Regarding to the indications of crystalline penicillin, the 
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study indicated that 81.58% of the indications were 
appropriate as per the STG, and this was found less 
performance as compared with the threshold set for 
indication of crystalline penicillin (100%)
 4,15,16
. This 
result is lower than the study conducted in Jimma 
University specialized hospital in pediatric ward where 
100% crystalline penicillin uses were found to be 
appropriate
19
. 
Coming to the dose of crystalline penicillin, different 
doses are used for varieties of infections and age groups. 
Subclinical use of the drug results in emergence of 
antimicrobial resistance and reduces the likelihood of 
having effective therapeutic outcomes whereas, over 
dose results in toxicological concerns. Therefore, 
optimal dose has to be used for better therapeutic 
outcomes 
16, 20
.  In this study, about 94.74% of medical 
records had correct doses of crystalline penicillin and the 
rest 5.26% of cases were associated with over dose 
practices assuming that there was no dose adjustment 
despite the presence of underlying clinical conditions. 
Unfortunately, there were no under dosing of crystalline 
penicillin identified at pediatric ward of HFSUH. 
Generally, the overall use of dosage was found very 
close to the threshold (95%) 
4, 16
. In this study, the use of 
crystalline penicillin when evaluated with regard to dose 
(94.74%) and dose frequency (98.14%) was found to be 
appropriate (on average, 96.29%) which is in line with 
WHO DUE guideline and STG of Ethiopia 
4,15,16
. In a 
study conducted at Jimma University specialized 
hospital (JUSH), the frequency of administration (100%) 
was found above the expected threshold (95%); 
however, the appropriateness of dosage prescribing 
(81.42%) was somewhat lower than the threshold (95%) 
15, 16, 19
. Averagely, doses and frequency given during the 
study at JUSH was 50,000 IU/kg every 4-6 hrs, but 
differ for various diseases 
19
.  
The duration of treatment of crystalline penicillin is 
concerned; drug resistance has become a great problem 
associated with premature discontinuation of therapy or 
shorter drug regimen than expected for the particular 
clinical condition. On the other way round, prolonged 
use of crystalline penicillin can also lead to emergence 
of antimicrobial drug resistance. Besides, long duration 
therapy may also cause normal flora to be affected and 
hence foreign infections easily develop resistance. 
Therefore, it should be used properly according to STGs. 
Inappropriate duration of therapy was the major problem 
revealed by this study. About 13.16% cards had 
unspecified duration of therapy and 35.09% had less 
than 3 days duration of therapy. Only 51.75% cards 
contain crystalline penicillin prescribed with appropriate 
duration of therapy, which is very far from the threshold 
set by the guideline (90%)
 15, 16
.  
Compared with the present finding, better duration of 
therapy of crystalline penicillin was found in pediatric 
wards of JUSH (83.6%) 
19
. Different results were 
reported from study done in Chandigarh, India on 
Penicillin and gentamicin therapy versus Amoxicillin/ 
Clavulanate in Severe hypoxemic pneumonia which 
explains that minimum duration of IV therapy was 3 
days and total of 7 days 
21
.  
In this study, the most common indication for crystalline 
penicillin injection was found to be severe pneumonia 
and community acquired pneumonia. Early diagnosis 
and appropriate case management by rational use of 
antibiotics remains one of the most effective 
interventions to reduce pneumonia-related mortality. As 
per the UNICEF/WHO report on pneumonia “estimates 
suggest that if antibiotic treatment were universally 
delivered to children with pneumonia, around 600,000 
lives could be saved each year 
22
. According to the some 
guidelines, all children diagnosed as severe pneumonia 
needs to be hospitalized for detailed assessment, 
injectable antibiotics, other supportive therapy and 
monitoring. Regarding choice of injectable antibiotics 
for in-patient treatment of severe community-acquired 
pneumonia; there is evidence that penicillins are superior 
to chloramphenicol 
23
. 
Regarding to the drug-drug interaction, the simultaneous 
uses of two or more drugs are recommended in specially 
defined situations based on pharmacologically rational 
use of drugs. However, selection of appropriate 
combinations requires an understanding of the potential 
for interaction between the drugs. Interactions may, 
otherwise, affect the patient therapeutic outcome 
negatively. In the study, there were no noticeable drug 
interactions (100%) and hence, the results are in line 
with the threshold set for drug interactions with 
crystalline penicillin (90%). Coming to contra-
indications, prescribing drugs, despite the presence of 
contraindication, should be avoided unless the benefits 
of therapy outweigh any potential risks. History of 
patients with known hypersensitivity reaction to 
crystalline penicillin and other antibiotics were not 
observed or documented. The result is in line with the 
threshold set for contra-indication for crystalline 
penicillin use which mandates (100% free from 
contraindication). This study is in concordant with the 
finding from JUSH where the actual performance of 
being freed from drug interactions and contra-indication 
were found to be 98.9% and 100%, respectively 
19
.  
Concerning to the clinical indication, this study 
identified that crystalline penicillin is incorrectly 
indicated for some disease which is non concordant with 
STG. Moreover, the purpose of treatment is empirical in 
majority of cases (61.41%). This show that unknowingly 
resistance is going to develop to crystalline penicillin 
since exact pathogen is not known or confirmed by 
laboratory investigation in the study hospital. So, in this 
hospital, prescribing crystalline penicillin without con-
firming laboratory result can lead to the development of 
resistance. This finding showed that among children 
admitted only 51.75% shows improvement which is too 
far from the threshold (95%). This result is also much 
lower than the finding from JUSH (91.80%) 
19
.  
Limitation  
Sufficient published studies have not obtained yet 
regarding the DUE of crystalline penicillin in Ethiopia. 
Hence, it was not possible to compare the practice of 
pediatrics ward of HFSUH with practice of other similar 
clinical settings. This finding was subjected to be 
discussed against the STG of Ethiopia and WHO DUE 
guideline. Even if, sampling was made as per JCHCAO 
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criteria, it is somewhat small to infer to the general 
population. Retrospective nature of the study had also 
some influence on the validity and completeness of the 
data for analysis and evaluation.  
CONCLUSION 
Crystalline penicillin utilization pattern in pediatric ward 
of HFSUH has fully adhered to the STG of Ethiopia for 
general hospitals and WHO Guideline for the majority 
of the parameters with regard to dose and frequency of 
administration, contraindications, and drug interactions 
as well as met the thresholds set for most of the DUE 
criteria. However, indication, duration and outcome of 
therapy were not in accordance with the guideline.  
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